Revisiting the gold standard: why 2-stage revision THA remains relevant for hip PJI: a 10-year experience with excellent infection-free survival

Background: 2-stage revision total hip arthroplasty (THA) remains the reference standard for the management of hip periprosthetic joint infection (PJI), despite increasing interest in 1-stage revision. This study reports the 10-year experience of a tertiary referral centre and evaluates infection control, implant survivorship, functional outcomes, and complications following staged revision. Methods: A retrospective review of prospectively collected data was performed for patients undergoing staged revision THA for hip PJI between 2014 and 2024. 65 patients met the inclusion criteria and were followed for a mean of 69.3 ± 28.9 months. Functional outcomes were assessed using the modified Harris Hip Score (mHHS). Kaplan-Meier analysis was used to determine implant survivorship, with reoperation, re-revision, recurrent infection, or mortality within 1 year of PJI treatment as survival endpoints. Results: An infection-free survival of 97.0% (63/65) was achieved at final follow-up. Only 2 patients (3.1%) developed recurrent infection, managed with debridement, antibiotics, and implant retention (DAIR) ( n = 1) or repeat 2-stage revision ( n = 1). Overall, implant survivorship was 87.6% (57/65). The remaining reoperations were attributable to mechanical failures, including aseptic loosening ( n = 3, 4.6%), recurrent dislocation ( n = 1, 1.5%), and periprosthetic fracture ( n = 1, 1.5%). The mean mHHS improved significantly from 26.0 ± 11.8 preoperatively to 68.9 ± 7.4 at final follow-up (mean improvement, 42.9 ± 9.6; p < 0.001). Conclusions: 2-stage revision THA provides excellent infection control, high implant survivorship, and significant functional improvement in patients with hip PJI. These findings reinforce its continued role as a reliable and reproducible treatment strategy, particularly in complex patients managed in real-world clinical practice.

Authors

Institutions

Publication Details

Journal
Hip International
Published
2026-11-18
DOI
https://doi.org/10.1177/11207000261492182
Primary Topic
Orthopedic Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Revisiting the gold standard: why 2-stage revision THA remains relevant for hip PJI: a 10-year experience with excellent infection-free survival

Mushtaq Saeed Qureshi, Michael Charles Wyatt, Nasir Ahmed, Sumaiya Khan et al.
Hip International
Orthopedic Infections and Treatments
article

Revisiting the gold standard: why 2-stage revision THA remains relevant for hip PJI: a 10-year experience with excellent infection-free survival

Mushtaq Saeed Qureshi, Michael Charles Wyatt, Nasir Ahmed, Sumaiya Khan, Prof. Syed Shahid Noor, Neelum Zehra Nazeer
article en

Abstract

Background: 2-stage revision total hip arthroplasty (THA) remains the reference standard for the management of hip periprosthetic joint infection (PJI), despite increasing interest in 1-stage revision. This study reports the 10-year experience of a tertiary referral centre and evaluates infection control, implant survivorship, functional outcomes, and complications following staged revision. Methods: A retrospective review of prospectively collected data was performed for patients undergoing staged revision THA for hip PJI between 2014 and 2024. 65 patients met the inclusion criteria and were followed for a mean of 69.3 ± 28.9 months. Functional outcomes were assessed using the modified Harris Hip Score (mHHS). Kaplan-Meier analysis was used to determine implant survivorship, with reoperation, re-revision, recurrent infection, or mortality within 1 year of PJI treatment as survival endpoints. Results: An infection-free survival of 97.0% (63/65) was achieved at final follow-up. Only 2 patients (3.1%) developed recurrent infection, managed with debridement, antibiotics, and implant retention (DAIR) ( n = 1) or repeat 2-stage revision ( n = 1). Overall, implant survivorship was 87.6% (57/65). The remaining reoperations were attributable to mechanical failures, including aseptic loosening ( n = 3, 4.6%), recurrent dislocation ( n = 1, 1.5%), and periprosthetic fracture ( n = 1, 1.5%). The mean mHHS improved significantly from 26.0 ± 11.8 preoperatively to 68.9 ± 7.4 at final follow-up (mean improvement, 42.9 ± 9.6; p < 0.001). Conclusions: 2-stage revision THA provides excellent infection control, high implant survivorship, and significant functional improvement in patients with hip PJI. These findings reinforce its continued role as a reliable and reproducible treatment strategy, particularly in complex patients managed in real-world clinical practice.

Hip International
Liaquat National Hospital (PK)
Orthopedic Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon